Abstract
Obesity and related metabolic dysregulation are risk factors for many types of cancer. The interactions between a developing tumor and its microenvironment are known to implicate a complex "crosstalk" among the factors produced by the population of cells. Among these factors, Growth and differentiation factor 15 (GDF15) has a functional role in cancer. GDF15 expression is induced in response to the conditions associated with cellular stress and diseases. The GDF15 receptor, a member of the glial-cell-derived neurotropic factor family (GDNF), is a GDNF family receptor α-like (GFRAL) protein. GDF15 induces pro-angiogenic effects in tumors. However, GDF15 could affect tumorigenesis both positively and negatively. With a better understanding of the upstream disease pathways reflected by GDF15, new treatment targets may emerge.
Keywords:
Angiogenesis; Cancer; GDF15; Obesity.
Copyright © 2020 Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Carcinogenesis / genetics*
-
Carcinogenesis / metabolism
-
Carcinogenesis / pathology
-
Cyclic AMP Response Element-Binding Protein / genetics
-
Cyclic AMP Response Element-Binding Protein / metabolism
-
Gene Expression Regulation, Neoplastic*
-
Growth Differentiation Factor 15 / genetics*
-
Growth Differentiation Factor 15 / metabolism
-
Humans
-
Inflammation
-
NF-kappa B / genetics
-
NF-kappa B / metabolism
-
Neoplasms / genetics*
-
Neoplasms / metabolism
-
Neoplasms / pathology
-
Neovascularization, Pathologic / genetics*
-
Neovascularization, Pathologic / metabolism
-
Neovascularization, Pathologic / pathology
-
Obesity / genetics*
-
Obesity / metabolism
-
Obesity / pathology
-
Signal Transduction
-
Smad Proteins / genetics
-
Smad Proteins / metabolism
-
Tumor Microenvironment / genetics*
Substances
-
CREB1 protein, human
-
Cyclic AMP Response Element-Binding Protein
-
GDF15 protein, human
-
Growth Differentiation Factor 15
-
NF-kappa B
-
Smad Proteins